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Strengths and limitations of this study
 ► This is the largest study of patient perspective in de-
generative cervical myelopathy (DCM) to date and 
the first to consider patient recovery priorities.
 ► This study is unique in reporting on both surgical 
and non-surgical DCM patients.
 ► This study includes a broad demographic represen-
tation of patients from across the globe and includes 
subgroup analysis.
 ► This is an open-access, internet-based survey, a 
methodology which can lead to a sampling bias.
 ► Efforts to mitigate against sampling bias, alongside 
reassuring subgroup analysis suggest this risk is 
low.
AbStrACt
Objectives To establish the recovery priorities of individuals 
suffering with degenerative cervical myelopathy (DCM).
Design A cross-sectional, observational study.
Setting Patients from across the world with a diagnosis 
of DCM accessed the survey over an 18-month period on  
Myelopathy. org, an international myelopathy charity.
Participants 481 individuals suffering from DCM 
completed the online survey fully.
Main outcome measures Functional recovery domains 
were established through qualitative interviews and a 
consensus process. Individuals were asked about their 
disease characteristics, including limb pain (Visual 
Analogue Scale) and functional disability (patient-derived 
version of the modified Japanese Orthopaedic Association 
score). Individuals ranked recovery domains (arm and 
hand function, walking, upper body/trunk function, sexual 
function, elimination of pain, sensation and bladder/bowel 
function) in order of priority. Priorities were analysed as 
the modal first priority and mean ranking. The influence of 
demographics on selection was analysed, with significance 
p<0.05.
results Of 659 survey responses obtained, 481 were 
complete. Overall, pain was the most popular recovery 
priority (39.9%) of respondents, followed by walking 
(20.2%), sensation (11.9%) and arm and hand function 
(11.5%). Sexual function (5.7%), bladder and bowel (3.7%) 
and trunk function (3.5%) were chosen less frequently. 
When considering the average ranking of symptoms, 
while pain remained the priority (2.6±2.0), this was 
closely followed by walking (2.9±1.7) and arm/hand 
function (3.0±1.4). Sensation ranked lower (4.3±2.1). With 
respect to disease characteristics, overall pain remained 
the recovery priority, with the exception of patients with 
greater walking impairment (p<0.005) who prioritised 
walking, even among patients with lower pain scores.
Conclusions This is the first study investigating patient 
priorities in DCM. The patient priorities reported provide an 
important framework for future research and will help to 
ensure that it is aligned with patient needs.
IntrODuCtIOn
Degenerative cervical myelopathy (DCM) 
has been coined as an umbrella term for 
degenerative and congenital or acquired 
conditions of the cervical spine, such as spon-
dylosis or ossification of the posterior longi-
tudinal ligament, which lead to symptomatic 
cord compression.1 With an estimated prev-
alence of up to 5% in individuals above 40 
years old,2 3 DCM is the most common cause 
of spinal cord dysfunction worldwide.1 Given 
its degenerative aetiology and the rising age 
of the population, this incidence is expected 
to rise.4
The cervical spinal cord acts as a processor 
and conduit of information between the brain 
and the periphery. Its injury can, therefore, 
give rise to a range of possible symptoms.1 
These include pain, paraesthesia, weakness, 
unsteadiness, frequent falls, bladder or bowel 
dysfunction and impotence in men.5 At early 
stages, individual symptoms may occur in 
isolation, but more typically occur in combi-
nation, especially as the disease advances.
At present, decompressive surgery is the 
only evidence-based treatment for DCM.6 
Surgical decompression is able to halt the 
progression of symptoms and offer limited, 
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although clinically-relevant7 improvements across a 
range of domains.8 9 However, due to the limited intrinsic 
capacity for the spinal cord to repair, most patients do not 
make a full recovery, and instead suffer lifelong disabili-
ties.9 As a consequence, unemployment and/or depen-
dency is prevalent among individuals with DCM.4 10 11 
Moreover, a recent study has identified that DCM severely 
impacts quality of life with recorded 36-Item Short Form 
Health Survey (SF-36), patient-reported outcome scores 
among the lowest of all chronic disease.12 Improving 
recovery is, therefore, a major unmet clinical need in 
DCM.13
Medical research is primarily designed by healthcare 
professionals. This bears the risk of not taking into 
account actual patient needs. The concept of ‘research 
wastage’ has emerged to depict healthcare research that 
does not yield actual or potential clinical benefit. In 
the 2014 Lancet series, Chalmers et al estimated that as 
much as 85% of the US$240 billion expended on health 
research in 2010 was wasted and an important contrib-
uting factor was the misalignment of patient and clini-
cian research objectives.14 15 As a consequence, several 
research funding bodies now advocate the involvement 
of patients in the design and conduct of research. This 
has demonstrable beneficial impact.16 Patient and public 
involvement (PPI) plays a particularly important role in 
the National Institute for Health Research.17 In addi-
tion to participation and engagement in the research 
process, the involvement of patients in identifying rele-
vant research topics and their prioritisation is particu-
larly encouraged. Organisations, such as the James Lind 
Alliance, have successfully brought together patients, 
professionals and industry in order to set research prior-
ities, for example, for spinal cord injury.18 However, the 
research priorities for individuals suffering from DCM 
have not yet been assessed.
A recent systematic review of DCM research demon-
strated a heavy focus on surgical technique.19 20 However, 
the research needs of patients with DCM and their prior-
ities remain unknown. Moreover, as part of a core-out-
comes initiative REsearch Objectives and COmmon 
Date Elements in DCM, we have identified that outcome 
domains are not consistently reported in current clinical 
research.19
In this study, we sought to establish the recovery needs 
and priorities of individuals suffering from DCM. This 
will help to determine the outcome assessments that 
should be included in clinical research and to better 
direct future research.
MethODS
Reporting adheres to the Enhancing the QUAlity and 
Transparency Of health Research (EQUATOR) Network 
Strengthening the Reporting of Observational Studies in 
Epidemiologychecklist.21
Survey design
Individuals with DCM and their caregivers were invited to 
attend the  Myelopathy. org PPI day, hosted at the Univer-
sity of Cambridge and captured by Cambridge TV in their 
documentary.22  Myelopathy. org is an international, char-
itable organisation for individuals affected by or working 
with DCM. As part of the event, qualitative interviews 
(n=9) were used to establish relevant functional domains 
that affected quality of life of individuals with DCM. These 
were found to resemble domains previously reported by 
Anderson et al, who conducted a survey among patients 
with traumatic spinal cord injury asking them to rank 
seven domains of spinal cord function in order of priority 
for recovery.23 Using this as a template but broadening 
upper body/trunk strength and balance’ to upper body/
trunk function, the following recovery domains were 
agreed by the participants: elimination of pain, arm and 
hand function, walking, sexual function, upper body/
trunk function, sensation and bladder/bowel function. 
For brevity, in this article, they are referred to as arm/
hand, walking, sexual function, pain, sensation, trunk 
and bladder/bowel.
These questions were embedded into an existing elec-
tronic survey initiative, developed using Survey Monkey 
(California, USA) and following the Checklist for 
Reporting Results of Internet E-Surveys,24 investigating 
patient reporting of DCM. This iteration was piloted by 
the lead investigators and a selection of individuals with 
DCM. Study objectives were outlined on the initial page, 
including details of the host organisation and estimated 
time required to complete the survey. This acted as the 
electronic consent, with continuation into the survey 
as agreement. Respondents were also presented with a 
description of DCM, including relevant synonyms, and 
required to confirm they suffered with the condition.
Respondents were asked to rank recovery domains in 
order of priority and provide details about their DCM. 
DCM characteristics included age, gender, history of 
surgery, best daily limb pain score (using a Visual Analogue 
Scale), duration of symptoms and disease severity as 
measured using the self-reported, patient-derived, modi-
fied Japanese Orthopaedic Association (P-mJOA).25 The 
mJOA is among the most commonly used assessments of 
disease severity19 20 and is fully- validated.26 It is a composite 
score based on upper limb function, lower limb function, 
upper limb sensation and bladder function. The score is 
valid for analysis in its entirety or per domain. Originally 
developed as an investigator-administered tool, it has 
recently been adapted and validated for use by patients.25 
All questions were mandatory, but respondents were not 
required to rank every recovery domain, on the basis 
that some domains may not be a priority for them. The 
sequence of questions and order of responses was not 
altered from respondent to respondent.
Survey administration
The survey was accessed via a landing page on  Myelopathy. 
org, allowing assessment of response rates using Google 
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Table 1 Summary of respondent demographics
Respondent demographics
Age (Mean±SD) 53.6 (9.8)
Male gender (%) 140 (29)
Undergone surgery (%) 221 (46)
Length of symptoms (%)
  0–1 year 72 (15)
  1–3 years 140 (29)
  3–10 years 181 (38)
  10–25 years 74 (15)
  25+years 14 (3)
P-mJOA (Mean+SD)
  Upper limb function 3.6 (1.0)
  Walking 4.4 (1.5)
  Upper limb sensation 1.7 (0.7)
  Bladder function 2.2 (1.0)
  Total 11.9 (3.0)
  VAS limb pain (Mean±SD) 3.1 (2.6)
P-mJOA, patient-derived version of the modified Japanese 
Orthopaedic Association; VAS, Visual Analogue Scale.
Analytics (California, USA). Individuals with DCM were 
recruited over an 18-month period. The recruitment 
process has been described in detail previously27 but in 
short, the survey was advertised using Google Adwords 
(California, USA) and through  Myelopathy. org and 
its social media outlets. The survey was voluntary and 
internet protocol addresses were used to prevent users 
submitting multiple responses. A missing data analysis 
was conducted between complete and incomplete survey 
responses to consider if particular subgroups were more 
likely to terminate early. Complete responders were 
defined as having provided answers for all aforemen-
tioned variables.
Analysis
Research priorities are presented using summary statis-
tics, including average ranking and overall proportion 
of patients per domain. Domains that were not ranked 
by a respondent were omitted from these scores. For 
subgroup analysis, variables were dichotomised and 
thresholds were chosen based on the graphical distribu-
tion of responses and sample sizes. Categorical variables 
were compared using the χ2 test. For continuous vari-
ables, the Shapiro-Wilk test was used to assess for para-
metric distribution of data sets. The Mann-Whitney U test 
was then used to compare the means of non-parametric 
distributions while a two-tailed t-test used to compare the 
means of parametric distributions. Pearson’s correlations 
were performed to assess between-group differences in 
characteristics, which could have influenced subgroup 
analysis. Significance was set at p<0.05.
Patient and public Involvement
Patients were involved in the design, development, recruit-
ment and conduct of this study. At a PPI day hosted at the 
University of Cambridge, a focus group of DCM patients 
evaluated and confirmed the recovery domains in DCM. 
DCM patients were used to pilot the subsequent survey, 
including optimising its design to reduce the time taken 
to complete and clarify questions. The online survey for 
the study was hosted on  Myelopathy. org, an international 
DCM charity run largely by DCM patients. Patients were, 
therefore, active in disseminating the survey via online 
DCM support groups, including Myelopathy Support, led 
by IS, patient and coauthor. Patients who were involved 
in preparation of the manuscript are among the authors. 
In addition, all patients who participated in the research 
are recognised in the acknowledgement statement. DCM 
patients are involved in plans to disseminate this research 
to the patient community, including blog articles on 
Myelopathy. org, posts in online patient support groups 
and presence at spinal conferences in the UK.
reSultS
respondents
The survey was uniquely accessed 1463 times, with 659 
visitors entering the survey (participation rate of 45%). A 
total of 481 responses contained complete data (comple-
tion rate 73%). A missing data analysis was conducted 
comparing incomplete and complete responses. Patients 
who completed the survey in full were more likely to 
have undergone surgery (p=0.04), otherwise there was 
no statistical difference within variables of interest (see 
online supplementary data 1). Only complete responses 
were analysed in the present study. Of these responses-
domains were ranked more than 80% of the time: pain 
(400, 83%), sensation (428, 89%), walking (396, 82%), 
arm and hand (393, 82%), sexual (388, 81%), bladder 
and bowel (399, 83%) and trunk function (407, 85%).
On average, respondents were more likely to be 
female (341, 71%) and suffer with moderate myelopathy 
(11.9±3.0) for between 3 and 10 years (181, 38%). Around 
half of patients (221, 46%) had undergone surgery. 
Overall respondent demographics are summarised in 
table 1. Considering group differences, patients who 
had suffered from the disease for longer appeared more 
likely to have undergone surgery (p=0.07) and have worse 
myelopathy (r=−0.22, p<0.005). They were also more 
likely to suffer greater pain (r=−0.14, p<0.01). Average 
pain scores were 3.1 (±2.4) for patients suffering with the 
disease for less than a year, rising to 4.5 (±3.0) for patients 
suffering for at least 10 years. There was no relationship 
between severity of myelopathy and pain scores (r=−0.04, 
p=0.36). Between-group differences are summarised in 
online supplementary data 2.
ranking of spinal cord dysfunction domains
Overall, pain was the most popular number one ranked 
recovery domain, chosen by 39.9% of respondents. This 
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Figure 1 Overall recovery priorities. The bar chart represents the first choice of patients and the line graph the average 
ranking for each domain (where the top ranking is 1). Pain was the overall first choice priority of patients, although when priority 
rankings were averaged, this was closely followed by walking and arm/hand function.
was followed by walking (20.2%), sensation (11.9%) and 
arm and hand function (11.5%). Sexual function (5.7%), 
bladder and bowel (3.7%) or trunk function (3.5%) were 
chosen less frequently. When considering the average 
ranking of symptoms, while pain remained the priority 
(2.6±2.0), this was closely followed by walking (2.9±1.7) 
and arm/hand function (3.0±1.4) (figure 1). Sensation 
ranked lower (4.3±2.1).
Impact of baseline characteristics on ranking of spinal cord 
dysfunction domains
Respondents who had undergone surgery were more 
likely to prioritise walking (p<0.005) and trunk function 
(p=0.03), whereas patients who had not yet undergone 
surgery were more likely to prioritise upper limb func-
tion (p<0.05) (figure 2). Patients with poor upper limb or 
lower limb function were more likely to prioritise arm/
hand recovery (p<0.005) and walking (p<0.005), respec-
tively (figure 2). Overall, pain remained the priority, 
with the exception of patients with the greatest walking 
impairment (p<0.005), even among patients with lower 
pain scores (figure 2).
When considering the average rankings pain, arm/hand 
function and walking remained the top three recovery 
priorities (figure 3). However, among the subcategories, the 
order of these priorities differed slightly (see online supple-
mentary data 3). Patients who were male, or who had under-
gone surgery, or who had greater upper limb, lower limb or 
bladder functional disability, prioritised recovery of walking, 
over pain and arm/hand function; patients with greater 
sensory disability prioritised recovery of arm/hand function 
over pain and walking.
When overall P-mJOA scores were considered to eval-
uate mild, moderate and severe patients,6 no variation 
was seen in modal or average ranked priorities.
DISCuSSIOn
This is the first study to systematically survey functional 
domains relevant to DCM and to ask patients to rank 
them in order of importance to their quality of life. The 
established priorities are likely to reflect symptom preva-
lence and their impact on day-to-day life.23 The analysis 
of 481 completed answers demonstrated that pain, arm/
hand function and walking emerge as the most important 
spinal cord dysfunction domains. Although based on 
averaged rankings, there were some subtle differences 
in ordering of these three domains. With the exception 
of patients with significant gait impairment, elimination 
of pain was the recovery priority independent of baseline 
characteristics.
These findings are surprising: functional disability 
(specifically recovery of arm/hand and walking 
function) has been and continues to be a focus for 
researchers, typically in response to surgery,8 but more 
recently with a shift towards enhancing postsurgical 
recovery.13 27 In contrast, pain is not widely recognised 
as an important relevant domain. Our recent review 
of outcome reporting in DCM clinical trials demon-
strated that the overwhelming majority of studies (90%) 
reported outcomes related to function, but only 27% 
of studies reported outcomes related to pain,19 despite 
the fact that pain is a well-recognised feature of DCM,5 
which often improves following surgery.11 The present 
findings highlight the fact that systematic research 
of patient needs is sorely lacking in DCM. A possible 
explanation for this discrepancy is that surgeons, who 
play a significant role in the management of DCM and 
predominate this research field, remain biased towards 
functional domains because pain is not a recognised 
indication for surgery in DCM.6
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Figure 2 Impact of baseline characteristics on first choice recovery priority. The bar chart represents the first choice of 
patients. Significant between-group differences are denoted by the * symbol. For simplicity, groups were dichotomised as 
follows: (A) duration of symptoms≤3 years, (B) male or female, (C) surgery or pre-surgery, (D) P-mJOA upper limb function≤2, 
(E) P-mJOA lower limb function≤3, (F) mJOA upper limb sensation≤1, (G) VAS limb pain≤3 and (H) P-mJOA bladder/bowel 
function≤1 . Those who had undergone surgery were more likely to choose trunk function (p=0.03) or walking function 
(p<0.005), whereas those who had not yet undergone surgery were more likely to choose arm/hand function (p<0.05). Equally 
patients with more impairment of walking (p<0.005) or arm/hand function (p<0.005) were more likely to prioritise these domains. 
Pain remained the priority even in patients reporting less pain. P-mJOA, patient-derived version of the modified Japanese 
Orthopaedic Association; VAS, Visual Analogue Scale.
The priorities established in the present study differ 
from those of individuals suffering from spinal cord 
injury. Although pain is among the most prevalent symp-
toms of traumatic spinal cord injury,28 29 the ‘elimination 
of chronic pain’ was considered to be a relatively low 
priority among those surveyed in Anderson’s study23 and 
a similar study by Kwon et al,30 that focused on the prior-
ities for SCI recovery after novel treatments (eg, stem 
cells). Instead, quadriplegics prioritised arm/hand func-
tion, while paraplegics sexual and bladder/bowel func-
tion. These differences relate to their specific significance 
for patient independence and quality of life.
In DCM, the symptom burden is less well-described31 32 
and the relationship between symptom burden or signifi-
cance with respect to quality of life in DCM has not been 
investigated. However, it would seem likely a similar rela-
tionship exists.
limitations
Following recommendation by the James Lind Alli-
ance, which was founded to support priority setting in 
research,33 34 the present survey was conducted online, 
as previously described, through a DCM charity,  Myelop-
athy. org.27 Respondents belonged to a self-selecting 
group of individuals who were asked to confirm they had 
been diagnosed with DCM by a medical professional, 
after being presented with a description of the disease 
for verification purposes. It is possible that some respon-
dents did not have DCM. Reassuringly, respondent demo-
graphics were comparable to those of leading prospective 
surgical studies, with the exception of gender, which was 
not shown to influence patient priorities8 9 (see online 
supplementary data 1). This likely reflects the recognised 
popularity of online health communities among females. 
There are no such comparable series for non-surgical 
cohorts, but their inclusion provides a further valuable 
perspective.
The survey questions were not randomly sorted and 
therefore each respondent answered identical surveys 
with spinal cord function domains presented in the same 
order. The last domain assessed was sensation. In keeping 
with it being the most prevalent DCM symptom,32 it 
featured most frequently in the responses, indicating that 
the order of domains was unlikely to have influenced the 
rankings. Moreover, answers to demographic questions, 
which followed the ranking of priorities in the survey, 
were required to define a complete response in order to 
be included in the present analysis. Priorities, therefore, 
were not influenced by incomplete answers.
Following the qualitative development work and the 
previous experience of Anderson et al, the pain domain 
was kept non-specific, asking patients to rank ‘elimination 
of pain’ as a recovery priority (see online supplementary 
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Figure 3 Impact of baseline characteristics on recovery priority average rankings. The scatter plot represents the mean 
ranking for each subgroup investigated. The blue line represents the overall average. Despite some discrepancies between 
subgroups, pain, arm/hand and walking function were consistently the top three priorities for patients. Bladder/bowel function 
was not a recovery priority. P-mJOA, patient-derived version of the modified Japanese Orthopaedic Association; VAS, Visual 
Analogue Scale.
data 4). In contrast, however, the pain assessment focused 
on limb pain, which is classically felt to represent DCM-re-
lated pain.5 While this does not limit the implications of 
our findings as whole, their interpretation will require a 
better characterisation of pain in DCM in order to focus 
research appropriately as other pain foci are reported.35
COnCluSIOn
The priorities reported in the present study identify func-
tional domains that are relevant to the quality of life of 
DCM patients. They provide an important framework for 
future research and will serve as a valuable reference for 
the development of a core outcome set relevant to studies 
in DCM.
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